We are live on ! Find out more
HOOK

HOOKIPA Pharma
HOOK

Delisted

HOOK was delisted on the 7th of August, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in HOOKIPA Pharma in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

9.11% less ownership

Funds ownership: 9.11% → 0% (-9.1%)

100% less funds holding

Funds holding: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $824K → $0 (-$824K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
–
Holders Change
-6
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
-$461K
2
JC
JBF Capital
Colorado
-$321K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$25K
4
XT
XTX Topco
Cayman Islands
-$16.7K
5
Osaic Holdings
Osaic Holdings
Arizona
-$466
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
– -$461K -498,625 Closed
JC
2
JBF Capital
Colorado
– -$321K -347,000 Closed
Acadian Asset Management
3
Acadian Asset Management
Massachusetts
– -$25K -28,020 Closed
XT
4
XTX Topco
Cayman Islands
– -$16.7K -18,056 Closed
Osaic Holdings
5
Osaic Holdings
Arizona
– -$466 -513 Closed

HOOK Hedge Fund Activity: Q4 2025 in Review

0 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in HOOKIPA Pharma (HOOK) for Q4 2025, worth a combined $0 — down 100% from $824K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of HOOK and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Knoll Capital Management, exiting entirely with an estimated $461K sold.

  • 0 institutional investors held HOOKIPA Pharma (HOOK) as of Q4 2025, down from 6 in Q3 2025.
  • Funds reported $0 of HOOKIPA Pharma stock for Q4 2025, down 100% quarter-over-quarter.
  • 0 funds opened new HOOKIPA Pharma positions in Q4 2025 and 6 closed out, a net change of -6 holders.
  • The largest HOOKIPA Pharma seller in Q4 2025 was Knoll Capital Management, an estimated $461K sold.

Based on aggregated 13F filings for Q4 2025.